Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSM ointment for refractory headache
IRCT20201228049868N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of nortriptyline, prednisolone, aspirin and biperiden in Headache (2 arms), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Primary endpoints: Headache severity, Duration of headache and 1 more. Started Jan 2021; status: completed.
02
Drugs
nortriptylineprednisoloneaspirinbiperiden
03
Conditions
Headache
Beyond the preview
Go deeper on IRCT20201228049868N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201228049868N1.